AIDS - Re-emergence of HIV after stopping therapy

[1] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J]. NATURE, 1997, 387 (6629) : 183 - 188

[2] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197

[3] Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8869 - 8873

[4] CHUN TW, 1999, NAT MED, V5, P615

[5] HIV/AIDS in 1998 - Gaining the upper hand? [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01): : 87 - 88

[6] DAVEY RT, IN PRESS P NATL ACAD

[7] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J]. NATURE MEDICINE, 1999, 5 (05) : 512 - 517

[8] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 734 - 739

[9] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 725 - 733

[10] Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) : 1605 - 1613

[1] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J]. NATURE, 1997, 387 (6629) : 183 - 188

[2] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197

[3] Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8869 - 8873

[4] CHUN TW, 1999, NAT MED, V5, P615

[5] HIV/AIDS in 1998 - Gaining the upper hand? [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01): : 87 - 88

[6] DAVEY RT, IN PRESS P NATL ACAD

[7] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J]. NATURE MEDICINE, 1999, 5 (05) : 512 - 517

[8] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 734 - 739

[9] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 725 - 733

[10] Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) : 1605 - 1613